Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.63 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 6/20 | 0.41 |
| ▸ | ABL1 | P00519 | 1/20 | 0.40 |
| ▸ | SCN9A | Q15858 | 4/20 | 0.36 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3740551 | 1.00 | CYP2C9 (0.63) | CYP2C9CYP3A4TRPM8TRPA1S1PR1 | |
| Hydrochloric Acid SCHEMBL3750538 | 0.99 | CYP2C9 (0.62) | CYP2C9CYP3A4TRPM8TRPA1S1PR1 | |
| Hydrochloric Acid SCHEMBL2789872 | 0.99 | CYP2C9 (0.62) | CYP2C9CYP3A4TRPM8TRPA1S1PR1 | |
| SCHEMBL2770465 | 0.99 | CYP3A4 (0.62) | CYP2C9CYP3A4TRPM8TRPA1S1PR1 | |
| SCHEMBL3745835 | 0.99 | CYP3A4 (0.62) | CYP2C9CYP3A4TRPM8TRPA1S1PR1 | |
| SCHEMBL3750911 | 0.89 | CYP2C9 (0.51) | CYP2C9CYP3A4TRPM8TRPA1S1PR1 | |
| SCHEMBL3750907 | 0.89 | CYP2C9 (0.51) | CYP2C9CYP3A4TRPM8TRPA1S1PR1 | |
| SCHEMBL3750963 | 0.87 | CYP3A4 (0.63) | CYP2C9CYP3A4TRPM8TRPA1TRPV1 | |
| SCHEMBL3750962 | 0.87 | CYP3A4 (0.63) | CYP2C9CYP3A4TRPM8TRPA1TRPV1 | |
| SCHEMBL3749516 | 0.87 | CYP3A4 (0.50) | CYP2C9CYP3A4TRPM8TRPA1S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8217060-B2 | Benzimidazole derivatives useful as TRP M8 receptor modulators | JANSSEN PHARMACEUTICA, NV (BE) | 2012-07-10 | — | — | US | claimed |
| US-20100292276-A1 | BENZIMIDAZOLE DERIVATIVES USEFUL AS TRP M8 RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA, NV (BE) | 2010-11-18 | — | — | US | claimed |
| US-8217060-B2 | Benzimidazole derivatives useful as TRP M8 receptor modulators | JANSSEN PHARMACEUTICA, NV (BE) | 2012-07-10 | — | — | US | disclosed |
| US-20100292276-A1 | BENZIMIDAZOLE DERIVATIVES USEFUL AS TRP M8 RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA, NV (BE) | 2010-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292276-A1 | BENZIMIDAZOLE DERIVATIVES USEFUL AS TRP M8 RECEPTOR MODULATORS | TRPM8, TRPV1, TRPA1 | CYP2C9 2805/4885CYP3A4 2735/4885TRPM8 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.